GlassScriptPhysician profile
Michael B Cannone
NPI 1275517328
$115,848.51
in general payments reported to CMS, 2019-2025
5 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $122 · 2021: $18K · 2022: $23K · 2023: $21K · 2024: $12K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $43K · Food and Beverage: $60.19 · Education: $42.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $43,457.03 |
| Food and Beverage | $60.19 |
| Education | $42.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nextstep Arthropedix, LLC | $115,556.33 | 2019-2025 | Insitu Hip System |
| Conformis, INC. | $122.41 | 2020 | |
| Innovation Technologies INC | $66.84 | 2022 | |
| Smith+Nephew, INC. | $60.19 | 2025 | Clancy, Novostitch, Spatial Frame |
| Vericel Corporation | $42.74 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cannone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.